SCHAMBYE HANS T. (Chief Executive Officer) sold 28.3% of their position (1.34K shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2025ACC: 0000950170-25-002811
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+15.06K
Net shares
Net buyer
$7.5K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
19.04K acquired · 3.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.64K
Price / share
—
Trade value
—
% of position
125.8%
1/3/2025
2.10K→4.74K
Common Stock
Direct
Shares
−1.34K
Price / share
$5.60
Trade value
$7.51K
% of position
28.3%
1/3/2025
4.74K→3.40K
Total
Net shares
+1.30K
Net value
-$7.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | M · Option Exercise | +2.64K | — | — | 125.8% | 2.10K | 4.74K |
| Common Stock Direct | 1/3/2025 | S · Sale | −1.34K | $5.60 | $7.51K | 28.3% | 4.74K | 3.40K |
| Total | +1.30K | -$7.51K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
2.64K shares
Shares
−2.64K
Strike price
Held after
5.36K
Exercisable
—
1/3/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.40K shares
Shares
+16.40K
Strike price
5.7
Held after
16.40K
Exercisable
—
1/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.64K shares | 1/3/2025 | M · Option Exercise | −2.64K | — | 5.36K | |
| Stock Option (right to buy) Direct | Common Stock16.40K shares | 1/3/2025 | A · Award | +16.40K | 5.7 | — | 16.40K |